Mechanisms maintaining peripheral tolerance

Nature Immunology

Volumn 11, Issue 1, 2010, Pages 21-27

  Mueller, Daniel L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOIMMUNITY; CELL SELECTION; CLONAL ANERGY; COMPLEX FORMATION; GENE DELETION; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIGAND BINDING; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTATION; APOPTOSIS; BIOLOGICAL MODEL; DENDRITIC CELL; IMMUNOLOGY;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 74049160009     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1817     Document Type: Review

References (87)

1. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
2. Torkamani, A., Topol, E.J. & Schork, N.J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92, 265-272 (2008).
3. Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2, 1032-1039 (2001).
4. Anderson, M.S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
5. Von Boehmer, H. & Melchers, F. Checkpoints in lymphocyte development and autoImmune disease. Nat. Immunol. 11, 14-20 (2010).
6. Wing, K. & Sakaguchi, S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13 (2010).
7. Liu, G.Y. et al. Low avidity Recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3, 407-415 (1995).
8. Goverman, J. et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72, 551-560 (1993).
9. Goverman, J. Tolerance and autoimmunity in TCr transgenic mice specific for myelin basic protein. Immunol. Rev. 169, 147-159 (1999).
10. Zehn, D. & Bevan, M.J. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 25, 261-270 (2006).
11. Henrickson, S.E. et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat. Immunol. 9, 282-291 (2008).
12. Lammermann, T. & Sixt, M. The microanatomy of T-cell responses. Immunol. Rev. 221, 26-43 (2008).
13. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
14. Mempel, T.R., Henrickson, S.E. & von Andrian, U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154-159 (2004).
15. Celli, S., Lemaitre, F. & Bousso, P. real-time manipulation of T cell-dendritic cell Interactions in vivo reveals the importance of prolonged contacts for CD4+ T cell activation. Immunity 27, 625-634 (2007).
16. Ohashi, P.S. et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305-317 (1991).
17. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M.K. visualizing the generation of memory CD4 T cells in the whole body. Nature 410; 101-105 (2001).
18. Masopust, D., Vezys, V., Marzo, A.L. & Lefrancois, L. Preferential localization of Effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
19. Austrup, F. et al. P-and e-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385, 81-83 (1997).
20. Reinhardt, R.L., Bullard, D.C., Weaver, C.T. & Jenkins, M.K. Preferential accumulation of antigen-specific Effector CD4 T cells at an antigen injection site involves CD62e-dependent migration but not local proliferation. J. Exp. Med. 197, 751-762 (2003).
21. Masopust, D. et al. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J. Immunol. 172, 4875-4882 (2004).
22. Bianchi, T. et al. Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOvA mice. J. Immunol. 182, 4665-4674 (2009).
23. Bursch, L.S., Rich, B.E. & Hogquist, K.A. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J. Immunol. 182, 4657-4664 (2009).
24. Mrass, P. & Weninger, W. Immune cell migration as a means to control Immune privILege: lessons from the CNS and tumors. Immunol. Rev. 213, 195-212 (2006).
25. Lee, J.W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8, 181-190 (2007).
26. Ackerman, A.L., Giodini, A. & Cresswell, P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25, 607-617 (2006).
27. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-780 (2001).
28. Liu, K. et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097 (2002).
29. Laufer, T.M., DeKoning, J., Markowitz, J.S., Lo, D. & Glimcher, L.H. Unopposed positive selection and autoreactivity in mice expressing class ii MHC only on thymic cortex. Nature 383, 81-85 (1996).
30. Laufer, T.M., Fan, L. & Glimcher, L.H. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J. Immunol. 162, 5078-5084 (1999).
31. Scheinecker, C., McHugh, R., Shevach, E.M. & Germain, R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090 (2002).
32. Luckashenak, N. et al. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28, 521-532 (2008).
33. Kerksiek, K.M., Niedergang, F., Chavrier, P., Busch, D.H. & Brocker, T. Selective rac1 Inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood 105, 742-749 (2005).
34. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255 (1999).
35. Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate Immune response. Cell 131, 1124-1136 (2007).
36. Lu, Q. & Lemke, G. Homeostatic regulation of the Immune system by receptor tyrosine kinases of the Tyro 3 famILy. Science 293, 306-311 (2001).
37. Wallet, M.A. et al. MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med. 205, 219-232 (2008).
38. Pasare, C. & Medzhitov, R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21, 733-741 (2004).
39. Jiang, A. et al. Disruption of e-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27, 610-624 (2007)
40. Morelli, A.E. & Thomson, A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610-621 (2007).
41. Lo, D., Burkly, L.C., Flavell, R.A., Palmiter, R.D. & Brinster, R.L. Tolerance in trans-genic mice expressing class ii major histocompatibILity complex on pancreatic acinar cells. J. Exp. Med. 170, 87-104 (1989).
42. Kearney, E.R., Pape, K.A., Loh, D.Y. & Jenkins, M.K. visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994).
43. Adler, A.J. et al. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J. Exp. Med. 187, 1555-1564 (1998).
44. Kurts, C. et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186, 2057-2062 (1997).
45. + T cells. J. Exp. Med. 186, 239-245 (1997).
46. Knoechel, B., Lohr, J., Kahn, E. & Abbas, A.K. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J. Immunol. 175, 21-26 (2005)
47. vanasek, T.L., Nandiwada, S.L., Jenkins, M.K. & Mueller, D.L. CD25+Foxp3+ Regulatory T cells facILitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J. Immunol. 176, 5880-5889 (2006).
48. Brown, I.E., Blank, C., Kline, J., Kacha, A.K. & Gajewski, T.F. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J. Immunol. 177, 4521-4529 (2006).
49. Tanchot, C., Barber, D.L., Chiodetti, L. & Schwartz, R.H. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J. Immunol. 167, 2030-2039 (2001).
50. Marrack, P. & Kappler, J. Control of T cell viabILity. Annu. Rev. Immunol. 22, 765-787 (2004).
51. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317 (1992).
52. BouILlet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999).
53. Davey, G.M. et al. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J. Exp. Med. 196, 947-955 (2002).
54. Strasser, A., Harris, A.W., Huang, D.C., Krammer, P.H. & Cory, S. Bcl-2 and Fas/ APO-1 regulate distinct pathways to lymphocyte apoptosis. eMBo J. 14, 6136-6147 (1995).
55. Weant, A.E. et al. Apoptosis regulators Bim and Fas function conCurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28, 218-230 (2008).
56. Hutcheson, J. et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28, 206-217 (2008).
57. Hughes, P.D. et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic Immune responses and prevention of autoimmunity. Immunity 28, 197-205 (2008).
58. Barron, L., Knoechel, B., Lohr, J. & Abbas, A.K. Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J. Immunol. 180, 2762-2766 (2008).
59. Parish, I.A. et al. The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood 113, 4575-4585 (2009).
60. Safford, M. et al. egr-2 and egr-3 are negative regulators of T cell activation. Nat. Immunol. 6, 472-480 (2005).
61. Macian, F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731 (2002).
62. Mondino, A. & Mueller, D.L. mTOr at the crossroads of T cell proliferation and tolerance. Semin. Immunol. 19, 162-172 (2007).
63. DeSILva, D.R., Urdahl, K.B. & Jenkins, M.K. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147, 3261-3267 (1991).
64. Harding, F.A., McArthur, J.G., Gross, J.A., raulet, D.H. & Allison, J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609 (1992).
65. Powell, J.D., Lerner, C.G. & Schwartz, R.H. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 162, 2775-2784 (1999).
66. Colombetti, S., Benigni, F., Basso, V. & Mondino, A. Clonal anergy is maintained independently of T cell proliferation. J. Immunol. 169, 6178-6186 (2002).
67. Finck, B.K., Linsley, P.S. & Wofsy, D. Treatment of murine lupus with CTLA4ig. Science 265, 1225-1227 (1994).
68. Racke, M.K. et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96, 2195-2203 (1995).
69. MILler, S.D. et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine eAe. Immunity 3, 739-745 (1995).
70. Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoRegulatory T cells that control autoImmune diabetes. Immunity 12, 431-440 (2000).
71. Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
72. Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of Resting T cells. J. Exp. Med. 183, 2533-2540 (1996).
73. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988 (1995).
74. Tivol, E.A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative Regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
75. Fife, B.T., Griffin, M.D., Abbas, A.K., Locksley, R.M. & Bluestone, J.A. Inhibition of T cell activation and autoImmune diabetes using a B cell surface-linked CTLA-4 agonist. J. Clin. Invest. 116, 2252-2261 (2006).
76. Kearney, E.R. et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1032-1036 (1995).
77. Perez, V.L. et al. induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417 (1997).
78. Vanasek, T.L., Khoruts, A., Zell, T. & Mueller, D.L. Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness. J. Immunol. 167, 5636-5644 (2001).
79. Greenwald, R.J., Boussiotis, V.A., Lorsbach, R.B., Abbas, A.K. & Sharpe, A.H. CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145-155 (2001).
80. wing, K. et al. CTLA-4 control over Foxp3+ Regulatory T cell function. Science 322, 271-275 (2008).
81. Eggena, M.P. et al. Cooperative roles of CTLA-4 and Regulatory T cells in tolerance to an islet cell antigen. J. Exp. Med. 199, 1725-1730 (2004).
82. Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupuslike autoImmune diseases by disruption of the PD-1 gene encoding an iTiM motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
83. Freeman, G.J. et al. engagement of the PD-1 immunoinhibitory receptor by a novel B7 famILy member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034 (2000).
84. Keir, M.E. et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203, 883-895 (2006).
85. Fife, B.T. et al. insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203, 2737-2747 (2006).
86. Fife, B.T. et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCr-induced stop signal. Nat. Immunol. advance online publication, doi:10.1038/nI.1790 (27 September 2009).
87. Probst, H.C., McCoy, K., Okazaki, T., Honjo, T. & van den Broek, M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6, 280-286 (2005).